-DOCSTART- -X- O
The -X- _ O
influenza -X- _ O
A -X- _ O
nucleoprotein -X- _ O
( -X- _ O
NP -X- _ O
) -X- _ O
is -X- _ O
an -X- _ O
attractive -X- _ O
target -X- _ O
for -X- _ O
avian -X- _ O
flu -X- _ O
vaccine -X- _ O
development -X- _ O
because -X- _ O
of -X- _ O
its -X- _ O
high -X- _ O
conversancy -X- _ O
in -X- _ O
the -X- _ O
evolutionary -X- _ O
chain -X- _ O
of -X- _ O
the -X- _ O
virus. -X- _ O
Here -X- _ O
we -X- _ O
identified -X- _ O
two -X- _ B-Intervention
novel -X- _ I-Intervention
HLA-A*0201 -X- _ I-Intervention
restricted -X- _ I-Intervention
NP -X- _ I-Intervention
epitopes -X- _ I-Intervention
, -X- _ I-Intervention
named -X- _ I-Intervention
H5N1 -X- _ I-Intervention
NP373-381 -X- _ I-Intervention
AMDSNTLEL -X- _ I-Intervention
( -X- _ I-Intervention
NP373 -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
NP458-466 -X- _ I-Intervention
FQGRGVFEL -X- _ I-Intervention
( -X- _ I-Intervention
NP458 -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ O
using -X- _ O
computational -X- _ O
bioinformatic -X- _ O
analysis. -X- _ O
The -X- _ O
NP -X- _ O
peptides -X- _ O
showed -X- _ O
a -X- _ O
high -X- _ O
binding -X- _ O
affinity -X- _ O
to -X- _ O
HLA-A*0201 -X- _ O
on -X- _ O
T2 -X- _ O
cells -X- _ O
, -X- _ O
and -X- _ O
were -X- _ O
able -X- _ O
to -X- _ O
induce -X- _ O
the -X- _ O
activation -X- _ B-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
cytotoxic -X- _ I-Outcome
T -X- _ I-Outcome
cells -X- _ I-Outcome
in -X- _ O
the -X- _ O
human -X- _ O
peripheral -X- _ O
blood -X- _ O
mononuclear -X- _ O
cells. -X- _ O
We -X- _ O
examined -X- _ O
the -X- _ O
potential -X- _ O
of -X- _ O
using -X- _ O
NP373 -X- _ B-Intervention
and -X- _ I-Intervention
NP458 -X- _ I-Intervention
peptide -X- _ O
sequences -X- _ O
supplemented -X- _ O
with -X- _ O
a -X- _ O
single-chain -X- _ O
trimer -X- _ O
as -X- _ O
potential -X- _ O
DNA -X- _ O
vaccine -X- _ O
candidates -X- _ O
in -X- _ O
an -X- _ O
HHD -X- _ B-Patient
transgenic -X- _ I-Patient
mouse -X- _ I-Patient
model. -X- _ I-Patient
A -X- _ O
gene -X- _ O
gun -X- _ O
delivery -X- _ O
system -X- _ O
was -X- _ O
used -X- _ O
for -X- _ O
administrating -X- _ O
the -X- _ O
vaccine -X- _ O
candidates -X- _ O
into -X- _ O
the -X- _ O
animals. -X- _ O
The -X- _ O
results -X- _ O
from -X- _ O
cytotoxicity -X- _ O
and -X- _ O
ELISPOT -X- _ O
assays -X- _ O
indicated -X- _ O
that -X- _ O
a -X- _ O
significant -X- _ O
amount -X- _ O
of -X- _ O
IFN-Î³ -X- _ B-Outcome
was -X- _ I-Outcome
secreted -X- _ I-Outcome
by -X- _ O
the -X- _ O
T -X- _ O
cells -X- _ O
of -X- _ O
the -X- _ O
vaccinated -X- _ O
mice -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
T -X- _ O
cells -X- _ O
were -X- _ O
able -X- _ O
to -X- _ O
eliminate -X- _ B-Outcome
the -X- _ I-Outcome
corresponding -X- _ I-Outcome
peptide- -X- _ I-Outcome
loaded -X- _ I-Outcome
T2 -X- _ I-Outcome
cells. -X- _ I-Outcome
The -X- _ O
discovery -X- _ O
of -X- _ O
these -X- _ O
novel -X- _ O
immunogenic -X- _ O
NP -X- _ O
peptides -X- _ O
provides -X- _ O
valuable -X- _ O
information -X- _ O
for -X- _ O
avian -X- _ O
flu -X- _ O
vaccine -X- _ O
design -X- _ O
and -X- _ O
construction -X- _ O
. -X- _ O

